Simpler Grants.gov #RFA-DK-27-147

Continuation of Integrated Islet Distribution Program (IIDP) for Diabetes Research

The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is seeking to continue the Integrated Islet Distribution Program (IIDP) via a single source cooperative agreement. - Government Buyer: - National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Eligible Applicant: - Beckman Research Institute/City of Hope is the only eligible applicant due to prior award eligibility - Program Purpose: - Continuation of the IIDP, which distributes human islets to biomedical researchers for diabetes research - Supports partnerships with islet isolation facilities for preparation and distribution of human islets - Products/Services Requested: - No specific commercial products or part numbers; focus is on research program support services - Service includes preparation and distribution of human islets for research - Notable Requirements: - Only U.S.-based organizations are eligible; foreign entities are excluded - Funding is part of the Special Diabetes Program - Supports critical diabetes research by enabling access to human islets

Description

This is a Notice of Funding Opportunity (NOFO) for a single source competition inviting applications from eligible organizations to continue the Integrated Islet Distribution Program (IIDP). The program supports the distribution of human islets to biomedical researchers to advance diabetes research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to issue a single source cooperative agreement to Beckman Research Institute/City of Hope to renew the IIDP. The IIDP facilitates partnerships with islet isolation facilities to provide human islets, which are essential for diabetes research and therapy development.

View original listing